Q&A: Eric Topol on How PBMs Are Driving PGx Testing Adoption in Place of Docs

In a recent commentary, Topol criticizes medical professionals for being "exceptionally resistant to change," and says that their demands for "suitable evidence" supporting PGx testing are a "cover for [their] profound lack of plasticity."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.